Sun Pharmaceutical Industries Ltd. said on Tuesday it plans to raise up to 35 billion rupees ($860 million) by issuing shares and/or debt in domestic and/or international markets.
The funds could be raised in more than one tranche, Sun, India's most valuable drug maker with a market capitalisation of $5 billion, said in a statement to the stock exchange.It would seek shareholders' approval for the planned issue, it said.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment